|
Delayed
Australian S.E.
04:10:10 19/10/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 1.035 AUD | -6.76% |
|
+1.47% | +146.43% |
| Market Cap | 238M 166M 148M 138M 125M 235M 15.79B 1.65B 648M 8.25B 624M 611M 26.37B | P/E 2025 |
17.8x | P/E 2026 | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 234M 163M 145M 135M 122M 230M 15.47B 1.62B 634M 8.08B 611M 599M 25.84B | EV / Sales 2025 |
2.82x | EV / Sales 2026 | 2.82x |
| Free-Float |
41.81% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| BLS | Delayed | |
Deutsche Boerse AG
| PR80 | Delayed | |
|
Boerse Muenchen
| PR80 | Real-time |
Last Transcript: BLS Pharmaceuticals Limited
| 1 day | -6.76% | ||
| 1 week | +1.47% | ||
| Current month | -1.43% | ||
| 1 month | -19.77% | ||
| 3 months | +19.65% | ||
| 6 months | +50.00% | ||
| Current year | +146.43% |
| 1 week | 1.02 |  | 1.13 |
| 1 month | 0.94 | | 1.27 |
| Current year | 0.36 | | 1.3 |
| 1 year | 0.35 | | 1.3 |
| 3 years | 0.04 | | 1.3 |
| 5 years | 0.04 | | 1.3 |
| 10 years | 0.04 | | 1.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sam Watson
CEO | Chief Executive Officer | - | 19/05/2023 |
Guy Robertson
DFI | Director of Finance/CFO | 72 | 01/09/2016 |
Jason Hine
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peng Ho
CHM | Chairman | 67 | 05/12/2012 |
Guy Robertson
BRD | Director/Board Member | 72 | 30/06/2022 |
Sam Watson
BRD | Director/Board Member | - | 19/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/5/26 | Buy | 5,000,000 | 0.2202% | |||
| 14/5/26 | Exercice | 5,000,000 | 0.2202% | |||
| 22/3/26 | Buy | Chief Executive Officer | 1,800,000 | 0.0804% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.76% | +1.47% | +165.38% | +840.91% | 178M | |
| -1.33% | +5.18% | +54.50% | +104.26% | 1,120B | |
| -0.69% | -2.93% | +31.35% | +66.17% | 616B | |
| -0.96% | +2.25% | +23.13% | +89.36% | 504B | |
| +0.24% | +6.23% | +33.98% | +52.38% | 367B | |
| -1.59% | -1.35% | +69.39% | +40.83% | 360B | |
| -0.40% | +4.28% | +19.17% | +42.51% | 288B | |
| -0.37% | +3.35% | -1.26% | +16.85% | 258B | |
| -1.75% | +2.43% | +42.21% | +49.85% | 234B | |
| -2.00% | +1.26% | +24.64% | +92.13% | 194B | |
| Average | -1.33% | +3.86% | +46.25% | +139.52% | 394.11B | |
| Weighted average by Cap. | -0.73% | +3.52% | +37.90% | +71.76% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 29.28M 20.43M 18.22M 16.89M 15.34M 28.82M 1.94B 203M 79.56M 1.01B 76.68M 75.05M 3.24B | 73.91M 51.58M 45.99M 42.64M 38.73M 72.76M 4.9B 511M 201M 2.56B 194M 189M 8.18B |
| Net income | 4.9M 3.42M 3.05M 2.83M 2.57M 4.82M 325M 33.9M 13.32M 170M 12.83M 12.56M 542M | 15.4M 10.75M 9.58M 8.88M 8.07M 15.16M 1.02B 106M 41.83M 533M 40.32M 39.47M 1.7B |
| Net Debt | -6.13M -4.28M -3.82M -3.54M -3.21M -6.04M -406M -42.43M -16.67M -212M -16.06M -15.72M -679M | -4.86M -3.39M -3.02M -2.8M -2.54M -4.78M -322M -33.59M -13.19M -168M -12.72M -12.45M -537M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/10/26 | $1.035 | -6.76% | 535,084 |
| 16/10/26 | $1.110 | +2.30% | 248,383 |
| 15/10/26 | $1.085 | 0.00% | 592,164 |
| 14/10/26 | $1.085 | +4.33% | 416,857 |
| 13/10/26 | $1.040 | +2.46% | 193,438 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BLS Stock
Select your edition
All financial news and data tailored to specific country editions
